Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1981 Jun;40(3):235-9.
doi: 10.1136/ard.40.3.235.

Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis

D R Swinson, J Zlosnick, L Jackson
Clinical Trial

Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis

D R Swinson et al. Ann Rheum Dis. 1981 Jun.

Abstract

Dapsone given over 14 weeks in a dose of 50 mg a day for 1 week and thereafter 100 mg a day was found to have a beneficial effect in rheumatoid arthritis when compared with placebo administration to a matched group of patients. Significant improvement in 5 out of 7 clinical measurements and in erythrocyte sedimentation rate, viscosity, C-reactive protein was found in those patients taking dapsone. There was significant improvement compared to the placebo group in 2 out of the 7 clinical measurements and again in all 3 acute-phase reactants. The drug was quite well tolerated over the 14-week duration of the trial. The tendency to cause haemolysis will be its main limiting factor as a practical alternative to other suppressive agents currently in use.

PubMed Disclaimer

References

    1. Q J Med. 1968 Jul;37(147):393-406 - PubMed
    1. Ann Intern Med. 1970 Apr;72(4):521-4 - PubMed
    1. Ann Rheum Dis. 1971 Nov;30(6):626-30 - PubMed
    1. Arch Dermatol. 1974 Oct;110(4):563-6 - PubMed
    1. Lancet. 1976 May 1;1(7966):964 - PubMed

Publication types